XCUR Exicure Inc

Price (delayed)

$1.24

Market cap

$8.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$6.4M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 3

Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its restructuring and suspension of clinical and development ...

Highlights
Exicure's EPS has soared by 66% YoY and by 15% from the previous quarter
The net income is up by 15% since the previous quarter but it is down by 5% year-on-year
XCUR's equity has dropped by 89% year-on-year and by 53% since the previous quarter
The quick ratio has plunged by 76% YoY and by 32% from the previous quarter

Key stats

What are the main financial stats of XCUR

XCUR stock price

How has the Exicure stock price performed over time
Intraday
-3.88%
1 week
-6.77%
1 month
7.83%
1 year
-64.67%
YTD
-77.12%
QTD
-40.38%

Financial performance

How have Exicure's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$4.06M
Net income
-$8.28M
Gross margin
N/A
Net margin
N/A
XCUR's operating income has surged by 74% year-on-year and by 26% since the previous quarter
The net income is up by 15% since the previous quarter but it is down by 5% year-on-year

Price vs fundamentals

How does XCUR's price correlate with its fundamentals

Growth

What is Exicure's growth rate over time

Valuation

What is Exicure stock price valuation
P/E
N/A
P/B
8.09
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Exicure's EPS has soared by 66% YoY and by 15% from the previous quarter
XCUR's equity has dropped by 89% year-on-year and by 53% since the previous quarter
XCUR's P/B is 72% above its 5-year quarterly average of 4.9 but 14% below its last 4 quarters average of 9.8

Efficiency

How efficient is Exicure business performance
XCUR's ROE has shrunk by 115% YoY and by 33% QoQ
The ROA has contracted by 28% YoY but it has grown by 3.7% from the previous quarter

Dividends

What is XCUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XCUR.

Financial health

How did Exicure financials performed over time
The company's total assets is 9% higher than its total liabilities
The quick ratio has plunged by 76% YoY and by 32% from the previous quarter
Exicure's current ratio has plunged by 70% YoY and by 29% from the previous quarter
The debt is 100% less than the equity
XCUR's equity has dropped by 89% year-on-year and by 53% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.